Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosisXiaobing Wang, Huji Xu, Xinyi Wan et al.|Cell|2024Cited by 272
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Huji Xu, Yi Zhang et al.|Cell|2025Cited by 61
Activation of the Peroxisome Proliferator–Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid ArthritisJian‐Da Ma, Lie Dai|Arthritis & Rheumatology|2019Cited by 27
Artemether Targets Raptor-Induced Actin Polymerization and Suppresses Migration of Fibroblast-like Synoviocytes in Rheumatoid ArthritisJian‐Da Ma, Lie Dai|Research Square|2021Cited by 0